Health

Research Updates on a Phase III Clinical Trial of Anbenitamab (KN026) Presented at ESMO Congress 2025 LBA Oral Presentation Session

SUZHOU, China, Oct. 18, 2025 /PRNewswire/ -- Alphamab Oncology (Stock Code: 9966.HK) announced that the first interim analysis results of a phase III clinical trial of anbenitamab injection (KN026), independently developed by the Company and co-developed with JMT-Bio Technology Co., Ltd., a wholl...

2025-10-18 14:59 2080

SCG announces presentation of clinical results of SCG142 in patients with HPV-related carcinoma at ESMO 2025

SINGAPORE, Oct. 18, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company developing next-generation immunotherapies for infectious diseases and their associated cancers, announced the presentation of first-in-human clinical data for SCG142 in an investigato...

2025-10-18 13:00 2456

One Heung Kong released the White Paper on Global Sustainable and Healthy Living Environments jointly with other institutions

GUANGZHOU, China, Oct. 18, 2025 /PRNewswire/ -- On October 14, the 2025 Global Engineering Conference and the first World Green Design Conference opened in Shanghai, China, drawing together over 250 former senior UN officials, academicians from different countries, and representatives from Fortune...

2025-10-18 11:06 2141

Multitude Therapeutics Announces Promising Interim Phase I/II Results from the Ongoing First-in-Human Study Evaluating its CD44v9-directed Antibody-Drug-Conjugate, AMT-116, in Heavily Pretreated EGFR Wild-type Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors at the 2025 ESMO Annual Meeting

AMT-116 is a potential first-in-class CD44v9-directed Topoisomerase I inhibitor-based ADC AMT-116 demonstrated a favorable safety profile, with manageable hematologic and Gastrointestinal toxicities Promising efficacies were observed in patients with heavily pretreated EGFR Wild-type NSCLC and ...

2025-10-17 22:00 3493

NYSE Content Advisory: Pre-Market Update + Automakers await 5-year tariff relief extension

NEW YORK, Oct. 17, 2025 /PRNewswire/ -- The New York Stock Exchange (NYSE) provides a daily pre-market update directly from the NYSE Trading Floor. Access today's NYSE Pre-market update for market insights before trading begins.    NYSE Content Advisory: Pre-Market Update + Automakers await 5-ye...

2025-10-17 20:55 2195

Kelun-Biotech's Core product Trastuzumab Botidotin Approved for Marketing by NMPA for HER2-positive BC

CHENGDU, China, Oct. 17, 2025 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") announced that the Company's human epidermal growth factor receptor 2 (HER2)-directed antibody-drug conjugate (ADC) trastuzumab botidotin (also known as A166)  was approved for marketi...

2025-10-17 20:22 1847

One Heung Kong released the White Paper on Global Sustainable and Healthy Living Environments jointly with other institutions

GUANGZHOU, China, Oct. 17, 2025 /PRNewswire/ -- On October 14, the 2025 Global Engineering Conference and the first World Green Design Conference opened in Shanghai, China, drawing together over 250 former senior UN officials, academicians from different countries, and representatives from Fortune...

2025-10-17 18:39 1612

One Heung Kong Leads the Way! New Global Benchmark for Healthy Living Announced

GUANGZHOU, China, Oct. 17, 2025 /PRNewswire/ -- On October 14, the 2025 Global Engineering Conference and the first World Green Design Conference opened in Shanghai, China, drawing together over 250 former senior UN officials, academicians from different countries, and representatives from Fortune...

2025-10-17 18:35 1258

HMI Medical Signs MOA With Ibraco Berhad To Acquire Land For The Establishment Of Its Third Hospital In Malaysia

The new tertiary hospital will be located within the NorthBank Township in Kuching,Sarawak and is targeted to launch in 2029 SINGAPORE, Oct. 17, 2025 /PRNewswire/ -- Health Mangement International Pte Ltd ("HMI Medical") has signed a Memorandum of Agreement ("MoA") with KLSE listed andSarawak-ba...

2025-10-17 16:49 1486

RITFIT Supports Breast Cancer Awareness Through Fitness at Making Strides Against Breast Cancer Walk

Home fitness brand RITFIT highlights women's empowerment and health advocacy with its Pink Series collection CHINO HILLS, Calif., Oct. 17, 2025 /PRNewswire/ -- RITFIT, a leading home fitness brand dedicated to empowering women through strength and wellness, sponsored and participated in the Maki...

2025-10-17 16:11 877

Chula Launches Newborn Genome Sequencing Project for Early Detection and Prevention of Genetic Diseases

BANGKOK, Oct. 17, 2025 /PRNewswire/ -- The Center of Excellence in Medical Genetics ,Faculty of Medicine , Chulalongkorn University

2025-10-17 16:00 1300

I-Mab Announces Intention to Undertake Strategic Transformation to Global Biotech Platform, to Pursue Hong Kong IPO, and Rebrand as NovaBridge Biosciences

* New business model reflects strategic transition to a global biotech platform focused on business development and translational clinical development to accelerate access to innovative medicines for patients worldwide * Intention to pursue a Hong Kong initial public offering (IPO) to expand ...

2025-10-17 15:21 2340

/C O R R E C T I O N -- Siemens Healthineers/

In the news release, NUH And NUS Launch New Molecular Imaging And Theranostic Centre To Strengthen Patient Care And Research, issued16-Oct-2025 by Siemens Healthineers over PR Newswire, we are advised by the company that the headline and 1st paragraph have been updated; all instances of Molecular...

2025-10-17 14:49 2325

FDA approves expanded pediatric indications for YUFLYMA® (adalimumab-aaty) and unbranded adalimumab-aaty in the United States

* YUFLYMA® (adalimumab-aaty), and its unbranded version, are now approved for two additional pediatric indications – adolescent hidradenitis suppurativa (HS) and pediatric uveitis (UV), in the U.S.[1],[2] * Pediatric UV is a rare eye inflammation in children, representing 5–10% of all uveitis...

2025-10-17 13:32 1202

Wang Qunbin: Innovation-Driven, Fosun's Path to Globalization

HONG KONG, Oct. 17, 2025 /PRNewswire/ -- On 16 October, the 2025 Sustainability Global Leaders Conference was held inShanghai. Themed "Joining Hands to Address Challenges: Global Action, Innovation, and Sustainable Growth", the Conference brought together approximately 500 guests fromChina and ab...

2025-10-17 11:17 2109

Illumina constellation mapped read technology uncovers hard-to-see genomic insights in GeneDx pilot

Illumina's up-and-coming constellation innovation delivers accuracy, speed, and ease of use in trial by GeneDx  Constellation outperformed orthogonal methods in identifying select difficult-to-mapvariants SAN DIEGO, Oct. 17, 2025 /PRNewswire/ -- Illumina, Inc. (NASDAQ: ILMN) announced that Gene...

2025-10-17 09:45 921

Invetech Wins 2025 Australian Good Design Award Gold for Excellence in Design and Innovation

SAN DIEGO, Oct. 17, 2025 /PRNewswire/ -- Invetech, a global leader in experience design-led instrument development, is proud to announce its work has been recognized with a prestigious 2025 Australian Good Design Award Gold for Digital Design Apps & Software. The award celebrates Invetech's comm...

2025-10-17 05:17 1093

MacuMira and Keeler announce global partnership to expand Dry AMD therapy

Partnership includes manufacturing and launch in Australia and New Zealand, with  additional markets to follow. WINDSOR, England and CALGARY, AB, Oct. 17, 2025 /PRNewswire/ -- Keeler

2025-10-17 04:35 950

A.D.A.M. Innovations and SOPHiA GENETICS partner to advance liquid biopsy testing and companion diagnostics for precision oncology in Japan

ROLLE, Switzerland and TOKYO, Oct. 16, 2025 /PRNewswire/ -- A.D.A.M. Innovations ,Japan's leading private genetic testing company, and SOPHiA GENETICS

2025-10-16 23:00 1612

Clarity signs copper-67 Supply Agreement with Nusano

SYDNEY, Oct. 16, 2025 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity" or "Company"), a clinical-stage radiopharmaceutical company with a mission to develop next-generation products that improve treatment outcomes for patients with cancer, is pleased to announce the signing of a Supp...

2025-10-16 21:04 1288
1 ... 26272829303132 ... 874